Health

Corporates frequently team up with each other to invest in startups. Who partners with who says a lot about how much a given team's track record is respected.

Third-quarter investment numbers show that investors are more trigger-happy, but not recklessly so.

The M Ventures team has seen a number of personnel changes recently, from a new managing director and CFO to principal and head of business operations.

Pharmaceutical firm Sanofi's corporate venture unit has added $625m to its evergreen fund following a succession of big exits.

Having completed his MBA and taken a couple of interim roles, Nikolas Koenning is back at The Cigna Group Ventures as principal.

After nearly 13 years working for the pharmaceutical company's venture arm, Marian Nakada has retired from corporate venturing.

The Oregon Health & Science University is the sole academic medical centre in the US state of Oregon.

Illumina Ventures started with a target of $300m for its latest fund but has cut that to $200m amid a tough climate for biotech investors.

Adele Moynihan has left her role as head of UK health insurer Bupa's APAC investment unit to join a health-tech startup.

The Mayo Clinic has hired entrepreneurs to speed the commercialisation of its medical research as funding from the government declines.

As sales of cameras and printers have declined, Canon Marketing Japan's VC unit has been tasked with finding new sources of revenue.